Influenza Virus · Clinical Data: Phase 1 Size: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg Atractylone...
Transcript of Influenza Virus · Clinical Data: Phase 1 Size: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg Atractylone...
Influenza Virus
Influenza virus belongs to the Orthomyxoviridae group, which are enveloped, segmented, single-stranded negative sense RNAviruses. The group includes three types of influenza viruses, A, B and C. Type B and C viruses only infect humans, but the type Aviruses infect humans, horses, swine, other mammals, and a wide variety of domesticated and wild birds. Human influenza A and Bviruses cause seasonal epidemics of disease almost every winter in the United States. The emergence of a new and very differentinfluenza virus to infect people can cause an influenza pandemic. Influenza type C infections cause a mild respiratory illness and arenot thought to cause epidemics. Each virus subtype has mutated into a variety of strains with differing pathogenic profiles; someare pathogenic to one species but not others, some are pathogenic to multiple species.
www.MedChemExpress.com 1
Influenza Virus Inhibitors & Antagonists
1-Deoxymannojirimycin hydrochlorideCat. No.: HY-W009783
1-Deoxymannojirimycin hydrochloride is a selective inhibitor with an class I α1,2-mannosidase IC50
of 20 μM. 1-Deoxymannojirimycin hydrochloride isalso a inhibitor and inhibitsN-linked glycosylation
strains. 1-Deoxymannojirimycin hydrochlorideHIV1has antiviral activity.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
3,4'-Dihydroxyflavone (3,4'-DHF) Cat. No.: HY-111802
3,4'-Dihydroxyflavone (3,4'-DHF) is an oral activeflavonoid with antiviral activity against Influenza
.A virus
Purity: 98.20%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg
3-DeoxysappanchalconeCat. No.: HY-N1745A
3-Deoxysappanchalcone is a naturally-occurringchalcone compound isolated from Caesalpinia sappan
(Leguminosae), which possesses anti-allergic,L.antiviral, anti-inflammatory and antioxidantactivities.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
3M-011Cat. No.: HY-121496
3M-011 is a potent dual toll-like receptor TLR7/8agonist and a cytokine inducer. 3M-011significantly inhibits H3N2 influenza viralreplication in the nasal cavity.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
5-AminouridineCat. No.: HY-130802
5-Aminouridine can modify nucleobases and can beincorporated into the target DNA. 5-Aminouridineexhibits a wide range of biological activity andit inhibits the growth of tumors, and .fungi viruses
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
6-AzathymineCat. No.: HY-136559
6-Azathymine, a 6-nitrogen analog of thymine, is apotent D-3-aminoisobutyrate-pyruvate
inhibitor. 6-Azathymineaminotransferaseinhibits the biosynthesis of , and hasDNAantibacterial and antiviral activities.
Purity: >98%Clinical Data: No Development ReportedSize: 100 mg, 250 mg, 500 mg
6-Diazo-5-oxo-L-nor-Leucine (L-6-Diazo-5-oxonorleucine; DON) Cat. No.: HY-108357
L-6-Diazo-5-oxonorleucine(L-6-Diazo-5-oxonorleucine) is a glutaminasesantagonist with a of 6 μM.Ki
L-6-Diazo-5-oxonorleucine exhibits analgesic,antibacterial, antiviral and anticancerproperties.
Purity: >99.0%Clinical Data: Phase 1Size: 10 mM × 1 mL, 1 mg, 5 mg
ABMACat. No.: HY-124801
ABMA is a broad-spectrum inhibitor ofintracellular toxins and pathogens. ABMAefficiently protects cells against various toxinsand pathogens including , viruses intracellular
and .bacteria parasite
Purity: 99.61%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg
Acetylcysteine (N-Acetylcysteine; N-Acetyl-L-cysteine; NAC) Cat. No.: HY-B0215
Acetylcysteine (N-Acetylcysteine) is a which reduces the thickness ofmucolytic agent
the mucus. Acetylcysteine is a inhibitor.ROS
Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 5 g, 10 g
AEBSF hydrochlorideCat. No.: HY-12821
AEBSF hydrochloride is an irreversible inhibitorof , such as chymotrypsin,serine proteaseskallikrein, plasmin, thrombin, and trypsin.
Purity: 99.90%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg, 200 mg
2 Tel: 609-228-6898 Fax: 609-228-5909 Email: [email protected]
AG-1478 (Tyrphostin AG-1478; NSC 693255) Cat. No.: HY-13524
AG-1478 (Tyrphostin AG-1478) is a selective EGFRtyrosine kinase inhibitor with of 3 nM.IC50
AG-1478 has antiviral effects against andHCV.encephalomyocarditis virus (EMCV)
Purity: 99.74%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg, 100 mg
Amantadine hydrochloride (1-Adamantanamine hydrochloride;
1-Adamantylamine hydrochloride; …) Cat. No.: HY-B0402A
Amantadine Hydrochloride is an antiviral and anantiparkinsonian drug. Target: Influenza VirusAmantadine Hydrochloride is an antiviral that isused in the prophylactic or symptomatic treatmentof influenza A.
Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 5 g, 10 g, 50 g
Andrographolide (Andrographis) Cat. No.: HY-N0191
Andrographolide is a inhibitor, whichNF-κBinhibits NF-κB activation through covalentmodification of a cysteine residue on inp50endothelial cells without affecting IκBαdegradation or p50/p65 nuclear translocation.Andrographolide has antiviral effects.
Purity: 97.46%Clinical Data: LaunchedSize: 100 mg, 500 mg
AprotininCat. No.: HY-P0017
Aprotinin is a bovine pancreatic trypsin inhibitor inhibitor which inhibits and(BPTI) trypsin
with s of 0.06 pM and 9 nM,chymotrypsin Ki
respectively.
Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg
Arctigenin ((-)-Arctigenin) Cat. No.: HY-N0035
Arctigenin is a lignan found in certain plants ofthe Asteraceae; it has shown antiviral andanticancer effects in glass; it is the aglycone ofarctiin. IC50 value: Target: anticancer agentArctiin and its aglucone, arctigenin from thefruits of Arctium lappa L.
Purity: 99.70%Clinical Data: Phase 1Size: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg
Atractylone (Atractylon) Cat. No.: HY-N2095
Atractylone (Atractylon) is a sesquiterpenoidextracted from . AtractyloneAtractylodis Rhizoma(Atractylon) alleviates influenza A virus(IAV)-induced lung injury via regulating the TLR7signaling pathway, and acts as a promising agentfor IAV treatment.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
Aurintricarboxylic acidCat. No.: HY-122575
Aurintricarboxylic acid is a nanomolar-potency,allosteric antagonist with selectivity towardsαβ-methylene-ATP-sensitive and ,P2X1Rs P2X3Rswith s of 8.6 nM and 72.9 nM for rP2X1R andIC50
rP2X3R, respectively.
Purity: >98%Clinical Data: No Development ReportedSize: 100 mg
Azadirachtin BCat. No.: HY-133108
Azadirachtin B is an limonoid isolated from seedkernels of . Azadirachtin BAzadirachta indicaincreases alkaline phosphatase (ALP) activity andstimulates osteoblast differentiation.Azadirachtin B is active against the Epstein-Barr
.virus early antigen (EBV-EA)
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
Baicalein (5,6,7-Trihydroxyflavone) Cat. No.: HY-N0196
Baicalein (5,6,7-Trihydroxyflavone) is a xanthine inhibitor with an value of 3.12 mM.oxidase IC50
Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg
Baloxavir (Baloxavir acid; S-033447) Cat. No.: HY-109025A
Baloxavir (Baloxavir acid) is a first-in-class,potent and selective cap-dependent endonuclease
inhibitor within the polymerase PA subunit(CEN)of and . Baloxavir inhibitsinfluenza A B virusesviral RNA transcription and replication and haspotently antiviral activity.
Purity: 99.75%Clinical Data: Phase 4Size: 10 mM × 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg
www.MedChemExpress.com 3
Baloxavir marboxil (S-033188) Cat. No.: HY-109025
Baloxavir marboxil is a small molecule inhibitorof the cap-dependent endonuclease of influenza Aand B viruses.
Purity: 99.95%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg
BenzimidazoleCat. No.: HY-Y1825
Benzimidazole is a heterocyclic aromatic organiccompound and acts as an important pharmacophore inmedicinal chemistry.
Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg
Beta-d-N4-hydroxycytidine (NHC) Cat. No.: HY-125033
Beta-d-N4-hydroxycytidine (NHC) is a very potent (venezuelan equine encephalitis virus)anti-VEEV
agent with , , and are 0.426,EC50 EC90 EC99
1.036, and 2.5 μM, respectively.
Purity: 98.36%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50 mg, 100 mg
Camphor ((±)-Camphor) Cat. No.: HY-N0808
Camphor ((±)-Camphor) is a topical anti-infectiveand anti-pruritic and internally as a stimulantand carminative. However, Camphor is poisonouswhen ingested. Antiviral, antitussive, andanticancer activities. Camphor is a TRPV3agonist.
Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg
Camptothecin (Campathecin; (S)-(+)-Camptothecin; CPT) Cat. No.: HY-16560
Camptothecin (Campathecin) is a potent DNA enzyme inhibitor, with an of 679topoisomerase I IC50
nM.
Purity: 98.62%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg
CarbodineCat. No.: HY-128718
Carbodine (Carbocyclic cytidine) is abroad-spectrum antiviral agent active against DNAviruses, (+)RNA viruses, (-)RNA viruses, paramyxo,rhabdo and (+/-)RNA viruses, targets CTPsynthetase that converts UTP to CTP.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
Catalpol (Catalpinoside) Cat. No.: HY-N0820
Catalpol, an iridoid glycoside, hasneuroprotective, anti-inflammatory, andanti-hepatitis virus effects. IC50 Value: Target:neuroprotective, anti-inflammatory, andanti-hepatitis virus natural product.
Purity: 98.04%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg
Catechin ((+)-Catechin; Cianidanol; Catechuic acid) Cat. No.: HY-N0898
Catechin ((+)-Catechin) inhibits cyclooxygenase-1( ) with an of 1.4 μM.COX-1 IC50
Purity: 99.23%Clinical Data: LaunchedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg
CBS1117Cat. No.: HY-131059
CBS1117 is a virus entry inhibitor with an ofIC50
70 nM for influenza A viruses, A/Puerto Rico/8/34(H1N1). CBS1117 interferes with the hemagglutinin(HA)-mediated fusion process.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
CEF1, Influenza Matrix Protein M1 (58-66)Cat. No.: HY-P0137
CEF1, Influenza Matrix Protein M1 (58-66) is anepitope derived from the matrix protein of theinfluenza A virus.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
4 Tel: 609-228-6898 Fax: 609-228-5909 Email: [email protected]
CEF3Cat. No.: HY-P0289
CEF3 (SIIPSGPLK) corresponds to aa 13-21 of theinfluenza A virus M1 protein. The matrix (M1)protein of influenza A virus is a multifunctionalprotein that plays essential structural andfunctional roles in the virus life cycle.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg, 10 mg
CEF6Cat. No.: HY-P0313
CEF6 is a 9-aa-long peptide corresponding to aa418-426 of the influenza A virus (H1N1)nucleocapsid protein.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg, 10 mg
CephaelineCat. No.: HY-N4118
Cephaeline is a phenolic alkaloid in Indian Ipecacroots. Cephaeline exhibits potent inhibition ofboth Zika virus (ZIKV) and Ebola virus (EBOV)infections.
Purity: >98.0%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
Cephalotaxlen ((-)-Cephalotaxine; ZINC19795976) Cat. No.: HY-N0838
Cephalotaxine is an antiviral as well as antitumoragent.
Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg, 100 mg
Chebulagic acidCat. No.: HY-N1996
Chebulagic acid is a COX-LOX dual inhibitorisolated from the fruits of Terminalia chebulaRetz, on angiogenesis. Chebulagic acid is a M2
inhibitorserine to asparagine 31 mutation (S31N)and influenza antiviral.
Purity: 99.29%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 2 mg, 5 mg, 10 mg, 25 mg
ChelidonineCat. No.: HY-N2369
Chelidonine is an isoquinoline alkaloid isolatedfrom , causes G arrestChelidonium majus L. 2/M
and induces caspase-dependent andcaspase-independent , with anticancer andapoptosisantiviral activity.
Purity: 99.03%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 1 mg, 5 mg, 10 mg
Chlorogenic acid (3-O-Caffeoylquinic acid; Heriguard; NSC-407296) Cat. No.: HY-N0055
Chlorogenic acid is a major phenolic compound incoffee and tea.
Purity: 99.43%Clinical Data: Phase 3Size: 10 mM × 1 mL, 500 mg
Chloroxylenol (4-Chloro-3,5-dimethylphenol; PCMX) Cat. No.: HY-B1414
Chloroxylenol is a broad spectrum antimicrobialchemical compound used to control bacteria, algae,fungi and virus. Target: AntibacterialChloroxylenol is used in hospitals and householdsfor disinfection and sanitation.
Purity: 99.20%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 5 g
Cinanserin hydrochloride (SQ 10643) Cat. No.: HY-100943
Cinanserin hydrochloride (SQ 10643) is a potent,selective and highly affinity 5-HT receptor2
antagonist with a of 41 nM. CinanserinKi
hydrochloride has a much higher binding affinityfor the than for the 5-HT receptor (5-HT2 1 Ki
of 3500 nM).
Purity: 99.74%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg
Cletoquine (Desethylhydroxychloroquine) Cat. No.: HY-135810
Cletoquine (Desethylhydroxychloroquine) is a majoractive metabolite of Hydroxychloroquine.Cletoquine is produced in the liver by CYP2D6,CYP3A4, CYP3A5, and CYP2C8 isoenzymes.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
www.MedChemExpress.com 5
Cletoquine oxalate (Desethylhydroxychloroquine oxalate) Cat. No.: HY-135810A
Cletoquine oxalate (Desethylhydroxychloroquineoxalate) is a major active metabolite ofHydroxychloroquine. Cletoquine oxalate is producedin the liver by CYP2D6, CYP3A4, CYP3A5, and CYP2C8isoenzymes.
Purity: >98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 50 mg, 100 mg
Coptisine chlorideCat. No.: HY-N0736
Coptisine chloride is an alkaloid from Chinesegoldthread, and acts as an efficient uncompetitive
inhibitor with a value of 5.8 μM and an IDO Ki IC50
value of 6.3 μM.
Purity: 99.29%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg, 100 mg
CoumarinCat. No.: HY-N0709
Coumarin is the primary bioactive ingredient inRadix Glehniae, named Beishashen in China, whichpossesses many pharmacological activities,including anticancer, anti-inflammation andantivirus activities.
Purity: 99.91%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg
Crystal Violet (Basic Violet 3; Gentian Violet; Methyl Violet 10B) Cat. No.: HY-B0324A
Crystal violet (Basic Violet 3) is atriarylmethane dye. Crystal Violet (GentianViolet) has antiviral effects against andH1N1also has prominent bactericidal activities.
Purity: 96.46%Clinical Data: Phase 3Size: 500 mg, 5 g, 10 g
Curcumin (Diferuloylmethane; Natural Yellow 3; Turmeric yellow) Cat. No.: HY-N0005
Curcumin (Diferuloylmethane), a natural phenoliccompound, is a p300/CREB-binding protein-specificinhibitor of acetyltransferase, represses theacetylation of histone/nonhistone proteins andhistone acetyltransferase-dependent chromatintranscription.
Purity: 96.31%Clinical Data: Phase 4Size: 10 mM × 1 mL, 100 mg, 500 mg
Curcumin D6 (Diferuloylmethane D6; Natural Yellow 3 D6;
Turmeric yellow D6) Cat. No.: HY-N0005S
Curcumin D6 (Diferuloylmethane D6) is a deuteriumlabeled Curcumin (Turmeric yellow). Curcumin(Turmeric yellow) is a natural phenolic compoundwith diverse pharmacologic effects includinganti-inflammatory, antioxidant, antiproliferativeand antiangiogenic activities.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
CyclofenilCat. No.: HY-W011100
Cyclofenil is a selective estrogen receptormodulator and an ovulation-inducing agent.Cyclofenil shows an inhibitory effect on dengue
replication in Vero cells with an ofvirus EC50
1.62 μM. Cyclofenil has anti-dengue-virusactivity.
Purity: >98%Clinical Data: LaunchedSize: 1 mg, 5 mg
Cynarin (Cynarine) Cat. No.: HY-N0359
Cynarin is an antichoke agent with a variety ofbiological activities including antioxidant,antihistamic and antiviral activities.
Purity: 99.96%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 25 mg
D-Pinitol (3-O-Methyl-D-chiro-inositol) Cat. No.: HY-N0655
D-pinitol (3-O-Methyl-D-chiro-inositol) is anatural compound presented in several plants, likePinaceae and Leguminosae plants. D-pinitol exertshypoglycemic activity and protective effects inthe cardiovascular system. D-pinitol has antiviraland larvicidal activities.
Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg
Daphnoretin (Dephnoretin; Thymelol) Cat. No.: HY-N0699
Daphnoretin (Dephnoretin), isolated from, possesses antiviralWikstroemia indica
activity. Daphnoretin likes PMA, may directactivation of protein kinase C which in turnactivated NADPH oxidase and elicited respiratoryburst.
Purity: 99.83%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 20 mg
6 Tel: 609-228-6898 Fax: 609-228-5909 Email: [email protected]
Dehydroandrographolide succinateCat. No.: HY-N0677
Dehydroandrographolide succinate, extracted fromherbal medicine (Burm f)Andrographis paniculataNees, is widely used for the treatment of viralpneumonia and viral upper respiratory tractinfections because of its immunostimulatory,anti-infective and anti-inflammatory effect.
Purity: 99.88%Clinical Data: LaunchedSize: 10 mM × 1 mL, 5 mg, 10 mg, 20 mg
DendrobineCat. No.: HY-N0638
Dendrobine is an alkaloid isolated from. Dendrobine possessesDendrobium nobile
antiviral activity against , withinfluenza A virusess of 3.39 μM, 2.16 μM and 5.32 μM forIC50
A/FM-1/1/47 (H1N1), A/Puerto Rico/8/34 H274Y(H1N1) and A/Aichi/2/68 (H3N2), respectively.
Purity: >98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 20 mg
Desaminotyrosine (3-(4-Hydroxyphenyl)propionic acid) Cat. No.: HY-W015346
Desaminotyrosine is a microbially associatedmetabolite protecting from throughinfluenzaaugmentation of signaling.type I interferon
Purity: 99.32%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg
DHODH-IN-2Cat. No.: HY-135570
DHODH-IN-2 (compound 21d) is a human inhibitor,dihydroorotate dehydrogenase (HsDHODH)
inhibits measles virus replication with a value of 8.6.pMIC50
Purity: 99.86%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg, 100 mg
DHODH-IN-5Cat. No.: HY-128787
DHODH-IN-5 is a potent human dihydroorotate inhibitor, with a ofdehydrogenase (DHODH) pIC50
7.8 for human recombinant DHODH. DHODH-IN-5inhibits measles virus replication, with a
of 8.8.pMIC50
Purity: 99.75%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg
DHODH-IN-9Cat. No.: HY-135667
DHODH-IN-9 (Compound 10k) is an azine-bearinganalogue and is a human dihydroorotate
inhibitor. DHODH-IN-9 has antiviraldehydrogenaseeffect with a pMIC of 7.4.50
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
DiphyllinCat. No.: HY-N2532
Diphyllin is an arylnaphthalene lignan isolatedfrom and is a potent Justicia procumbens HIV-1inhibitor with an IC50 of 0.38 μM. Diphyllin isactive against vesicular stomatitis virus (VSV)and .influenza virus
Purity: >98%Clinical Data: No Development ReportedSize: 10 mg, 25 mg
Dryocrassin ABBA (Dryocrassin) Cat. No.: HY-N0530
Dryocrassin ABBA (Dryocrassin) is a flavonoidnatural product derived from Dryopteris
, with antiviral and antibacterialcrassirhizomaactivities. Dryocrassin ABBA exhibits antiviralactivity against avian influenza virus.H5N1
Purity: >98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg
Duramycin (Moli1901; Lancovutide) Cat. No.: HY-106302
Duramycin (Moli1901;Lancovutide) is a cyclicpeptide lantibiotic derived from Streptomyces
. Duramycin stimulates chloridecinnamoneumasecretion in airway epithelium and has thepotential for cystic fibrosis treatment.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
EHNA hydrochlorideCat. No.: HY-103160A
EHNA hydrochloride is a potent and selective dualinhibitor of cyclic nucleotide phosphodiesterase 2
( =4 μM) and .(PDE2) IC50 adenosine deaminase (ADA)
Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 2 mg, 5 mg
www.MedChemExpress.com 7
EIDD-2801Cat. No.: HY-135853
EIDD-2801 is an orally bioavailable prodrug of theribonucleoside analog EIDD-1931. EIDD-2801 hasbroad spectrum antiviral activity against influenza
and multiple , such asvirus coronaviruses, , .SARS-CoV-2 MERS-CoV SARS-CoV
Purity: 99.90%Clinical Data: No Development ReportedSize: 10 mg, 50 mg, 100 mg
ElemicinCat. No.: HY-N6807
Elemicin is a alkenylbenzene widely distributed inmany herbs and spices. Elemicin inhibits
by metabolicStearoyl-CoA Desaturase 1 (SCD1)activation. Elemicin is one of the main componentsin aromatic food and has antimicrobial,antioxidant, and antiviral activities.
Purity: 98.39%Clinical Data: No Development ReportedSize: 5 mg
Eleutheroside B1Cat. No.: HY-135646
Eleutheroside B1, a coumarin compound, has a widespectrum of anti-human efficacy,influenza viruswith an value of 64-125 µg/ml.IC50
Eleutheroside B1 mediates its anti-influenzaactivity through POLR2A and N-glycosylation.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
Emricasan (PF 03491390; IDN-6556) Cat. No.: HY-10396
Emricasan (PF 03491390) is an orally active andirreversible inhibitor. Emricasanpan-caspaseinhibits -induced increases inZika virus (ZIKV)
activity and protected human corticalcaspase-3neural progenitors.
Purity: 99.88%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg, 100 mg
EpigoitrinCat. No.: HY-N0224
Epigoitrin is a natural alkaloid from Isatis, with antiviral activities. Epigoitrinindigotica
reduces susceptibility to influenza virus viamitochondrial antiviral signaling.
Purity: 99.91%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 20 mg
ErmaninCat. No.: HY-N3848
Ermanin is a flavonoid isolated from Tanacetum. Ermanin potently inhibits ,microphyllum iNOS
activities, and inhibits plateletCOX-2aggregation. Ermanin has anti-inflammatory,anti-tuberculous and anti-viral/bacterialproperties.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
Favipiravir (T-705) Cat. No.: HY-14768
Favipiravir (T-705) is a novel viral RNA inhibitor, it is phosphoribosylatedpolymerase
by cellular enzymes to its active form,Favipiravir-ribofuranosyl-5′-triphosphate (RTP).
Purity: 99.92%Clinical Data: LaunchedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg, 100 mg
FGI-106Cat. No.: HY-124618
FGI-106 is a potent and broad-spectrum inhibitorwith inhibitory activity against multiple viruses.FGI-106 is active against , andEbola Rift Valley
with s of 100 nM, 800Dengue Fever viruses EC50
nM and 400-900 nM, respectively.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
FGI-106 tetrahydrochlorideCat. No.: HY-124618A
FGI-106 tetrahydrochloride is a potent andbroad-spectrum inhibitor with inhibitory activityagainst multiple viruses. FGI-106tetrahydrochloride is active against , Ebola Rift
and with s of 100Valley Dengue Fever viruses EC50
nM, 800 nM and 400-900 nM, respectively.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
Fluticasone (propionate)Cat. No.: HY-B0154
Fluticasone propionate is a high affinity,selective GR (glucocorticoid receptor) agonistwhich is derived from fluticasone used to treatasthma and allergic rhinitis.
Purity: 99.97%Clinical Data: LaunchedSize: 10 mM × 1 mL, 10 mg, 50 mg
8 Tel: 609-228-6898 Fax: 609-228-5909 Email: [email protected]
FTI-277 hydrochlorideCat. No.: HY-15872A
FTI-277 hydrochloride is an inhibitor of farnesyl; a highly potent Ras CAAXtransferase (FTase)
peptidomimetic which antagonizes both andH-. FTI-277 hydrochlorideK-Ras oncogenic signaling
can inhibits hepatitis delta virus (HDV)infection.
Purity: >99.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg, 100 mg
Ganoderic acid TRCat. No.: HY-129150
Ganoderic acid TR is a broad-spectrum inhibitoragainst ,influenza neuraminidases (NAs)particularly H5N1 and H1N1 neuraminidases. The
values of 10.9 and 4.6 μM, respectively.IC50
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
GeldanamycinCat. No.: HY-15230
Geldanamycin is a inhibitor withHsp90antimicrobial activity against many Gram-positiveand some Gram-negative bacteria. Geldanamycin hasanti-influenza virus activities.H5N1
Purity: 99.78%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg
GeniposideCat. No.: HY-N0009
Geniposide is an iridoid glucoside extracted from fruits; exhibits a varityGardenia jasminoides Ellis
of biological activities such as anti-diabetic,antioxidative, antiproliferative andneuroprotective activities.
Purity: 99.52%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg, 100 mg, 500 mg
GermacroneCat. No.: HY-N0440
Germacrone is extracted from Rhizoma. Germacrone inhibits Curcuma influenza virus
infection.
Purity: >98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 20 mg
Ginsenoside Rb2 (Ginsenoside C) Cat. No.: HY-N0040
Ginsenoside Rb2 is one of the main bioactivecomponents of ginseng extracts. Rb2 can upregulate
gene expression. Ginsenoside Rb2 hasGPR120antiviral effects.
Purity: 98.26%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg
GlabranineCat. No.: HY-N3942
Glabranine, an flavonoid, is isolated fromTephrosia s.p, exerts a inhibitory effect in vitroon the dengue virus. Glabranine forms interactionwith the soluble ectodomain of DENV type 2( ) E protein.DENV2
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
Glaucine (O,O-Dimethylisoboldine; S-(+)-Glaucine; NSC 34396) Cat. No.: HY-N3945
Glaucine (O,O-Dimethylisoboldine) is an alkaloidisolated from Crantz withGlaucium flavumantitussive, bronchodilation and anti-inflammatoryproperties.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
Glycitin (Glycitein 7-O-β-glucoside) Cat. No.: HY-N0012
Glycitin is a natural isoflavone isolated fromlegumes; promotes the proliferation of bone marrowstromal cells and osteoblasts and suppresses boneturnover.Glycitin is antibacterial, antiviral andestrogenic.
Purity: 98.55%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 25 mg, 50 mg
GS-441524Cat. No.: HY-103586
GS-441524, predominant metabolite of Remdesivirand superior to Remdesivir against Covid-19 ,shows comparable efficacy in cell-based models ofprimary human lung and cat cells infected withcoronavirus.
Purity: 99.77%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg, 100 mg
www.MedChemExpress.com 9
GSK 650394Cat. No.: HY-15192
GSK 650394 is a novel inhibitor with ofSGK IC50
62 nM and 103 nM for SGK1 and SGK2 in the SPAassay respectively. GSK 650394 also inhibits
replication.influenza virus
Purity: 99.76%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg
HaemanthamineCat. No.: HY-114489A
Haemanthamine is a crinine-type alkaloid isolatedfrom the plants with potentAmaryllidaceaeanticancer activity. Haemanthamine targetsribosomal that inhibits protein biosynthesisduring the elongation stage of translation.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
Haemanthamine hydrochlorideCat. No.: HY-114489B
Haemanthamine hydrochloride is a crinine-typealkaloid isolated from the Amaryllidaceaeplants with potent anticancer activity.Haemanthamine hydrochloride targets ribosomal thatinhibits protein biosynthesis during theelongation stage of translation.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
HarringtonineCat. No.: HY-N0862
Harringtonine is a natural alkaloidCephalotaxusthat inhibits . Harringtonine hasprotein synthesisanti- activities with anchikungunya virus (CHIKV)
of 0.24 μM.EC50
Purity: 99.91%Clinical Data: LaunchedSize: 10 mM × 1 mL, 5 mg, 10 mg
HesperadinCat. No.: HY-12054
Hesperadin is an ATP-competitive inhibitor of kinase with an of 250 nM.aurora B IC50
Purity: 98.48%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg, 100 mg
HypericinCat. No.: HY-N0453
Hypericin is a photosensitive antiviral withanticancer and antidepressant agent derived fromHypericum perforatum. It can inhibit tyrosinekinases with IC50 of 7.5 μM.
Purity: >98.0%Clinical Data: Phase 1Size: 10 mM × 1 mL, 1 mg, 5 mg, 10 mg, 25 mg
HyperosideCat. No.: HY-N0452
Hyperoside, a natural flavonoid, isolated from, possesses antifungal,Camptotheca acuminate
anti-inflammatory, anti-viral, anti-oxidative andanti-apoptotic activities.
Purity: 98.35%Clinical Data: LaunchedSize: 5 mg, 10 mg, 20 mg
Impulsin (AM 3112; Loramine P 256; Mackpeart DR 14V) Cat. No.: HY-20685
Impulsin (AM 3112) is an active endogenouscompound which can used for preventing virusinfection of the respiratory tract.
Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg
Influenza A NP(366-374) Strain A/PR/8/35Cat. No.: HY-P1788
Influenza A NP(366-374) Strain A/PR/8/35 is anH2-Db-restricted epitope from Influenza A/PR/8/35nucleoprotein.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
Influenza A virus-IN-1Cat. No.: HY-131179
Influenza A virus-IN-1 is a dihydropyrrolidonesderivative and is a potent inhibitor against widesubtypes of with valuesinfluenza A virus (IAV) IC50
from 3.11 μM to 7.13 μM.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
10 Tel: 609-228-6898 Fax: 609-228-5909 Email: [email protected]
Influenza HA (307-319)Cat. No.: HY-P1749
Influenza HA (307-319) is 13 amino acids 307 to319 fragment of Influenza HA. Influenza HA is aglycoprotein found on the surface of influenzaviruses.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
Influenza NP (147-155)Cat. No.: HY-P1762
Influenza NP (147-155) is a K restricted epitoped
from influenza nucleoprotein.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
Influenza NP (147-155) (TFA)Cat. No.: HY-P1762A
Influenza NP (147-155) TFA is a K restrictedd
epitope from influenza nucleoprotein.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
Iniparib (BSI-201; NSC-746045; IND-71677) Cat. No.: HY-12015
Iniparib (BSI-201) is an irreversible inhibitor of, used in the research of triple negativePARP1
breast cancer.
Purity: 99.87%Clinical Data: Phase 3Size: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg, 200 mg, 500 mg
Isoferulic acid (3-Hydroxy-4-methoxycinnamic acid) Cat. No.: HY-N0761
Isoferulic acid (3-Hydroxy-4-methoxycinnamic acid)is a cinnamic acid derivative that hasantidiabetic activity. Isoferulic acid binds toand activates α1-adrenergic receptors (IC =1.4 µM)50
to enhance secretion of β-endorphin (EC =52.250
nM) and increase glucose use.
Purity: 99.82%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg
Isoliquiritigenin (GU17; ISL; Isoliquiritigen) Cat. No.: HY-N0102
Isoliquiritigenin is an anti-tumor flavonoid fromthe root of , which inhibits Glycyrrhiza glabra aldose
with an of 320 nM.reductase IC50
Isoliquiritigenin is a potent inhibitor of replication with an of 24.7influenza virus EC50
μM.
Purity: 98.24%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg, 200 mg
IsomangiferinCat. No.: HY-N0772
Isomangiferin, a natural product, is reported tohave antiviral activity.
Purity: 99.85%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg
JNJ4796Cat. No.: HY-122907
JNJ4796 is an oral active fusion inhibitor of, neutralizing influenza A group 1influenza virus
viruses by inhibiting hemagglutinin-mediated fusion. JNJ4796 mimics the(HA)
functionality of the broadly neutralizingantibodies (bnAbs).
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
Kaempferide (Kaempferol 4'-O-methyl ether) Cat. No.: HY-15449
Kaempferide is an O-methylated flavonol, a type ofchemical compound. It can be found in Kaempferiagalanga (aromatic ginger).
Purity: 99.42%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg
KIN101Cat. No.: HY-126113
KIN101 is a potent inhibitor with sRNA viral IC50
of 2 μM, >5 μM for and Dengueinfluenza virusvirus (DNV), respectively. KIN101, an isoflavoneagonist of dependent signaling, induces IRF-3IRF-3nuclear translocation. KIN101 has broad-spectrumactivity against RNA viruses.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
www.MedChemExpress.com 11
KIN1148Cat. No.: HY-101950
KIN1148, a small-molecule agonist, is a novelIRF3influenza vaccine adjuvant found to enhance fluvaccine efficacy.
Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 1 mg, 5 mg, 10 mg, 50 mg, 100 mg
L-Norleucine ((S)-Norleucine; (S)-2-Aminohexanoic acid) Cat. No.: HY-Y0017
L-Norleucine is an isomer of leucine, specificallyaffects protein synthesis in skeletal muscle, andhas antivirus activity.
Purity: >98.0%Clinical Data: Phase 2Size: 10 mM × 1 mL, 500 mg, 1 g
LactimidomycinCat. No.: HY-18979
Lactimidomycin is a glutarimide-containingcompound isolated from .StreptomycesLactimidomycin is a potent inhibitor of eukaryotic
.translation elongation
Purity: >98%Clinical Data: No Development ReportedSize: 200 μg
Lanatoside CCat. No.: HY-B1030
Lanatoside C is a cardiac glycoside, can be usedin the treatment of congestive heart failure andcardiac arrhythmia.Lanatoside C has an IC50 of0.19 μM for dengue virus infection in HuH-7 cells.
Purity: 99.08%Clinical Data: LaunchedSize: 10 mM × 1 mL, 10 mg
Laninamivir (R 125489) Cat. No.: HY-14818
Laninamivir (R 125489) is a potent influenza inhibitor with s ofneuraminidase (NA) IC50
0.90 nM, 1.83 nM and 3.12 nM for avian H12N5 NA(N5), pH1N1 N1 NA (p09N1) and A/RI/5+/1957 H2N2 N2(p57N2), respectively.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
LapacholCat. No.: HY-N6961
Lapachol is a naphthoquinone that was firstisolated from (Bignoniaceae).Tabebuia avellanedae
Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mg, 50 mg, 100 mg
Lonafarnib (Sch66336) Cat. No.: HY-15136
Lonafarnib is an orally bioavailable farnesylprotein transferase ( ) inhibitor for H-ras,FPTaseK-ras and N-ras with of 1.9 nM, 5.2 nM andIC50
2.8 nM, respectively. Lonafarnib has anti-hepatitis activities.delta virus (HDV)
Purity: 98.67%Clinical Data: Phase 3Size: 10 mM × 1 mL, 5 mg, 10 mg
Loratadine (Loratidine; SCH 29851) Cat. No.: HY-17043
Loratadine (SCH-29851) is a selective inverseperipheral histamine H1-receptor agonist with anIC50 of >32 μM. Loratadine has anti-dengue-virus
activity.(DENV)
Purity: 99.95%Clinical Data: LaunchedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg
Loxoribine (7-Allyl-8-oxoguanosine; RWJ 21757) Cat. No.: HY-108472
Loxoribine (7-Allyl-8-oxoguanosine) is a guanosineanalog with anti-viral and anti-tumor activities.Loxoribine is an orally bioavailable and selective
agonist.Toll-like receptor (TLR) 7
Purity: >97.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg
M2 ion channel blockerCat. No.: HY-75867
M2 ion channel blocker is capable of inhibitingand blocking the activity of M2 ionchannel;Antiviral agent.
Purity: >95.0%Clinical Data: No Development ReportedSize: 100 mg
12 Tel: 609-228-6898 Fax: 609-228-5909 Email: [email protected]
M2e, humanCat. No.: HY-P1783
M2e, human, consisting of the 23 extracellularresidues of M2 (the third integral membraneprotein of influenza A), has been remarkablyconserved in all human influenza A, which is avalid and versatile vaccine candidate to protectagainst any strain of human influenza A.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
M2e, human TFACat. No.: HY-P1783A
M2e, human TFA, consisting of the 23 extracellularresidues of M2 (the third integral membraneprotein of influenza A), has been remarkablyconserved in all human influenza A. M2e, human TFAis a valid and versatile vaccine candidate toprotect against any strain of human influenza A.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
ML303Cat. No.: HY-126136
ML303 is a pyrazolopyridine influenza virus antagonist ( =nonstructural protein 1 (NS1) IC90
155 nM), with an of 0.7 μM for Influenza AEC50
virus H1N1.
Purity: >98.0%Clinical Data: No Development ReportedSize: 1 mg
Moroxydine hydrochloride (ABOB hydrochloride) Cat. No.: HY-B0420A
Moroxydine hydrochloride (ABOB hydrochloride) is asynthetic antiviral compound chemically belongingto the series of the heterocyclic biguanidines.
Purity: 99.89%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg, 1 g, 5 g, 10 g
Mycophenolic acid (Mycophenolate) Cat. No.: HY-B0421
Mycophenolic acid (Mycophenolate) is an animmunosuppresant drug and has potentanti-proliferative activity.
Purity: 99.63%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg, 1 g
N-Acetylneuraminic acid (NANA; Lactaminic acid) Cat. No.: HY-I0400
N-Acetylneuraminic acid is a nine-carbon, sialicacid monosaccharide commonly found inglycoproteins on cell membranes and in glycolipidssuch as gangliosides in mammalian cells.
Purity: >95.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg, 1 g
N-Glycolylneuraminic acid (NeuGc; GcNeu) Cat. No.: HY-128965
N-Glycolylneuraminic acid is a nonhuman sialicacid molecule synthesized in pigs but not inhumans. N-Glycolylneuraminic acid works as a decoyreceptor of N-Glycolylneuraminic acid-binding
.influenza A viruses (IAVs)
Purity: >98%Clinical Data:Size: 1 mg, 5 mg
N6-Methyladenosine (6-Methyladenosine; N-Methyladenosine) Cat. No.: HY-N0086
N6-Methyladenosine is the most prevalent internal(non-cap) modification present in the messengerRNA (mRNA) of all higher eukaryotes.N6-Methyladenosine can modifies and hasviral RNAsantiviral activities.
Purity: 99.07%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg, 500 mg
NaringeninCat. No.: HY-N0100
Naringenin is the predominant flavanone ingrapefruit; displays strong anti-inflammatory andantioxidant activities. Naringenin has anti-dengue
activity.virus (DENV)
Purity: 98.72%Clinical Data: Phase 1Size: 10 mM × 1 mL, 100 mg, 500 mg, 1 g, 5 g
Netropsin dihydrochlorideCat. No.: HY-N6800A
Netropsin (dihydrochloride) is a small-moleculeMGB (minor-groove binder), inhibits the catalyticactivity of isolated topoisomerase and interfereswith the stabilization of the cleavable complexesof topoisomerase II and I in nuclei.
Purity: 98.05%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
www.MedChemExpress.com 13
NimbinCat. No.: HY-N3187
Nimbin is a intermediate limonoid isolated from. Nimbin prevents aggregation andAzadirachta tau
increases cell viability. Nimbin is effectiveinhibits the .envelope protein of dengue virus
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
Nitazoxanide (NTZ; NSC 697855) Cat. No.: HY-B0217
Nitazoxanide is a syntheticnitrothiazolyl-salicylamide derivative and anantiprotozoal agent. (IC50 for canine influenzavirus ranges from 0.17 to 0.21 μM).
Purity: 98.03%Clinical Data: LaunchedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg
Nitazoxanide D4 (NTZ D4; NSC-697855 D4) Cat. No.: HY-B0217S
Nitazoxanide D4 is the deuterium labeledNitazoxanide, which is an antiprotozoal agent.
Purity: >98.0%Clinical Data: No Development ReportedSize: 1 mg, 5 mg, 10 mg
NITD008 (7-Deaza-2'-C-acetylene-adenosine) Cat. No.: HY-12957
NITD008 is a potent and selective flaviviruseinhibitor which can inhibit Dengue Virus Type 2
with an of 0.64 μM.(DENV-2) EC50
Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 1 mg, 5 mg, 10 mg
Nonactin (Ammonium ionophore I) Cat. No.: HY-N6790
Nonactin is a naturally occurring macrotetrolideantibiotic from . NonactinStreptomyces griseusacts as an ionophore for monovalent cations,including . Nonactin is able toK , and NH+
4+
uncouple the oxidative phosphorylation ofmitochondria.
Purity: >99.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 1 mg, 5 mg
NucleozinCat. No.: HY-50001
Nucleozin targets influenza A nucleoprotein (NP),a multifunctional, RNA-binding protein necessaryfor virus replication. IC50 Value: Target:Influenza Virus NP Nucleozin targets influenza Anucleoprotein, a multifunctional, RNA-bindingprotein necessary for virus replication.
Purity: 99.74%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 25 mg, 50 mg
Octyl gallate (n-Octyl gallate; Stabilizer GA 8) Cat. No.: HY-N2011
Octyl gallate (Progallin O) is widely used as afood additive, with antimicrobial and antioxidantactivity. Octyl gallate (Progallin O) showsselective and sensitive fluorescent property.
Purity: 99.96%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg
Oseltamivir acid (GS 4071; Ro 64-0802; Oseltamivir carboxylate) Cat. No.: HY-13318
Oseltamivir acid (GS 4071), the active metaboliteof Oseltamivir phosphate, is an orallybioavailable, potent and selective inhibitor of
withinfluenza virus neuraminidase ( =2 nM)IC50
activity against both influenza A and B viruses.
Purity: 99.54%Clinical Data: LaunchedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg
Oseltamivir acid D3 (GS 4071 D3; Ro 64-0802 D3; Oseltamivir carboxylate D3) Cat. No.: HY-13318S
Oseltamivir acid D3 (GS 4071 D3) is a deuteriumlabeled Oseltamivir acid.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
Oseltamivir D3Cat. No.: HY-13317S
Oseltamivir D3 is a deuterium labeled Oseltamivir.Oseltamivir is an influenza virus neuraminidaseinhibitor (NAI). Oseltamivir inhibits influenzaA/H3N2, A/H1N2, A/H1N1, and B viruses with mean
s of 0.67, 0.9, 1.34 and 13 nM, respectively.IC50
Anti-influenza A and B agent.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
14 Tel: 609-228-6898 Fax: 609-228-5909 Email: [email protected]
Oseltamivir phosphate (GS 4104) Cat. No.: HY-17016
Oseltamivir phosphate (GS 4104) is a neuraminidaseinhibitor recommended for the treatment andprophylaxis of and .influenza A B
Purity: 99.85%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg
OxymatrineCat. No.: HY-N0158
Oxymatrine, an alkaloid from the roots of Sophoraspecies, with anti-inflammatory, antifibrosis, andantitumor effects, inhibits the expression andiNOS
pathway.TGF-β/Smad
Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 200 mg, 500 mg, 1 g
PA (224-233), InfluenzaCat. No.: HY-P1580
PA (224-233), Influenza is a 10-aa peptide, afragment of polymerase 2 protein in influenza Avirus.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg, 10 mg
Pentagalloylglucose (Penta-O-galloyl-β-D-glucose;
1,2,3,4,6-Pentagalloyl glucose) Cat. No.: HY-N0527
Pentagalloylglucose (Penta-O-galloyl-β-D-glucose)is a gallotannin isolated from various plants.
Purity: 99.50%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg, 100 mg
Peramivir (RWJ-270201; BCX-1812) Cat. No.: HY-17015A
Peramivir (RWJ-270201;BCX-1812) is a highlypotent, selective and orally active influenzavirus inhibitor, with neuraminidase (NA) IC50
values ranging form 0.9 to 4.3 nM for nine NAsubtypes.
Purity: >98%Clinical Data: LaunchedSize: 1 mg, 5 mg
Peramivir trihydrate (RWJ 270201 trihydrate; BCX 1812 trihydrate) Cat. No.: HY-17015
Peramivir trihydrate (RWJ-270201trihydrate;BCX-1812 trihydrate) is a highlypotent, selective and orally active influenzavirus inhibitor, with neuraminidase (NA) IC50
values ranging from 0.9 to 4.3 nM for nine NAsubtypes.
Purity: 99.40%Clinical Data: LaunchedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg
PhillyrinCat. No.: HY-N0482
Phillyrin is isolated from Forsythia suspensa Vahl(Oleaceae), has antibacterial andanti-inflammatory activities. Phillyrin haspotential inductive effects on rat andCYP1A2
activities, without affecting CYP2C11 andCYP2D1CYP3A1/2 activities.
Purity: 98.99%Clinical Data: LaunchedSize: 10 mM × 1 mL, 5 mg, 10 mg, 20 mg
Picroside IICat. No.: HY-N0408
Picroside II, an iridoid compound extracted from, exhibits anti-inflammatory andPicrorhiza
anti-apoptotic activities. picroside II alleviatesthe inflammatory response in sepsis and enhancesimmune function by inhibiting the activation of
inflammasome and pathways.NLRP3 NF-κB
Purity: 99.77%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg, 100 mg
Pimodivir (VX-787) Cat. No.: HY-12353A
Pimodivir (VX-787) is an orally bioavailableinhibitor of influenza A virus polymerasesthrough interaction with the viral subunit.PB2
Purity: 99.45%Clinical Data: Phase 3Size: 10 mM × 1 mL, 2 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg
PP7Cat. No.: HY-100858
PP7 is a potent PB1-PB2 interaction inhibitor withan of 8.6 μM, and their inhibition againstIC50
viral polymerase activity ( =9.5 μM). PP7 showsIC50
antiviral activities against influenza A virus(IAV), including A(H1N1)pdm09 ( =1.4 μM),EC50
A(H7N9) and A(H9N2) subtypes.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
www.MedChemExpress.com 15
Psoralen (Furocoumarin; Ficusin) Cat. No.: HY-N0053
Psoralen (Furocoumarin) is an active ingredientfrom Fructus Psoraleae; has anticancer activity.IC50 value: Target: in vitro: Psoralen dosages of1-10 μM exhibited low cytotoxicity towardchondrocytes.
Purity: 99.84%Clinical Data: Phase 3Size: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg
Rifampicin (Rifampin; Rifamycin AMP) Cat. No.: HY-B0272
Rifampicin is a potent and broad spectrumantibiotic against pathogens. Rifampicinbacterialhas anti- activities.influenza virus
Purity: 98.07%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 1 g, 5 g
RIG-1 modulator 1Cat. No.: HY-107902
RIG-1 modulator 1 is an anti-viral compound whichcan be useful for the treatment of viralinfections including , , andinfluenza virus HBV HCV
extracted from patent WO 2015172099 A1.HIV
Purity: 99.04%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 1 mg, 5 mg, 10 mg, 50 mg
Rimantadine (1-Rimantadine) Cat. No.: HY-B0338
Rimantadine (Flumadine) is an anti-influenza virusdrug. Target: Influenza Virus rimantadine are oralantiviral drugs useful in the prophylaxis andtreatment of influenza A virus infections.
Purity: >98%Clinical Data: LaunchedSize: 1 mg, 5 mg
Rimantadine hydrochlorideCat. No.: HY-B0338A
Rimantadine hydrochloride is an anti-influenzavirus drug. Target: Influenza Virus Rimantadinehydrochloride are oral antiviral drugs useful inthe prophylaxis and treatment of influenza A virusinfections.
Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 1 g
RO-7Cat. No.: HY-112684
RO-7 is a next-generation polymerase (PA)endonuclease inhibitor of influenza A and Bviruses.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
Rupestonic acidCat. No.: HY-N3016
Rupestonic acid, a sesquiterpene from Artemisia L., can inhibit .rupestris influenza virus
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
Rutin (Rutoside; Quercetin 3-O-rutinoside) Cat. No.: HY-N0148
Rutin, a naturally occurring flavonoid glycoside,has antioxidant, anti-inflammatory, anti-allergic,anti-angiogenic and antiviral properties.
Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 500 mg, 5 g, 10 g
S119-8Cat. No.: HY-112543
S119-8 is a broad spectrum inhibitor of influenza and .A B viruses
Purity: 99.49%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg
SC75741Cat. No.: HY-10496
SC75741 is a broad and efficient inhibitorNF-κBwith an of 200 nM for . SC75741 blocksIC50 p65
replication. SC75741 impairsinfluenza viruses (IV)DNA binding of the subunit p65, resultingNF-κBin reduced expression of cytokines, chemokines,and pro-apoptotic factors.
Purity: 99.51%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg
16 Tel: 609-228-6898 Fax: 609-228-5909 Email: [email protected]
Scriptaid (Scriptide; GCK1026) Cat. No.: HY-15489
Scriptaid is a potent histone deacetylase (HDAC)inhibitor, used in cancer research. Scriptaid isalso a sensitizer to antivirals and has potentialfor epstein-barr virus (EBV)-associated lymphomastreatment.
Purity: 99.12%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg
Sodium copper chlorophyllin BCat. No.: HY-B2226
Sodium copper chlorophyllin B exerts antiviralactivities against and with sInfluenza virus HIV IC50
of 50 to 100 μM for both of them.
Purity: >98%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g
SophocarpineCat. No.: HY-N0103
Sophocarpine is one of the significant alkaloidextracted from the traditional herb medicine
which has many pharmacologicalSophora flavescensproperties such as anti-virus, anti-tumor,anti-inflammatory.
Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 20 mg
Sophocarpine monohydrateCat. No.: HY-N0103A
Sophocarpine (monohydrate) is one of thesignificant alkaloid extracted from thetraditional herb medicine whichSophora flavescenshas many pharmacological properties such asanti-virus, anti-tumor, anti-inflammatory.
Purity: >99.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg
SP187 (MON-DNJ; UV4) Cat. No.: HY-U00160
SP187 is a host-targeted iminosugar with activityagainst filovirus infections in vitro and in vivo.SP187 is active against influenza and dengue invivo.
Purity: 99.30%Clinical Data: No Development ReportedSize: 1 mg, 5 mg, 10 mg, 20 mg
Spermine (NSC 268508; Neuridine) Cat. No.: HY-B1777
Spermine (NSC 268508) functions directly as a freeradical scabenger to protect DNA from free radicalattack. Spermine has antiviral effects.
Purity: >98.0%Clinical Data: Phase 1Size: 10 mM × 1 mL, 100 mg
T-1105Cat. No.: HY-W015764
T-1105, a novel broad-spectrum viral polymeraseinhibitor, structural analogue of T-705, inhibitsthe polymerases of RNA viruses after beingconverted to ribonucleoside triphosphate (RTP)metabolite.
Purity: 96.17%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 100 mg
T-705RTPCat. No.: HY-135803
T-705RTP is a selective and GTP-competitive inhibitor with aninfluenza virus RNA polymerase
of 0.14 μM and a of 1.52 μM. T-705RTP isIC50 Ki
the active triphosphate metabolite of T-705 andhas potent anti-influenza virus activity.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
T-705RTP sodiumCat. No.: HY-135791
T-705RTP sodium is a selective and GTP-competitive inhibitor with aninfluenza virus RNA polymerase
of 0.14 μM and a of 1.52 μM. T-705RTPIC50 Ki
sodium is the active triphosphate metabolite ofT-705 and has potent anti-influenza virusactivity.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
Tenuazonic acidCat. No.: HY-N6715
Tenuazonic acid, belonging to tetramic acids thatare the largest family of natural products, is aputative nonhost-selective mycotoxin isolated from
.Alternaria alternate
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
www.MedChemExpress.com 17
TetrahydroepiberberineCat. No.: HY-N3035
Tetrahydroepiberberine is a isoquinoline alkaloidisolated from (Pall).Corydalis impatiensTetrahydroepiberberine has and selectiveantifungalinhibition against the activities.PI-3 virus
Purity: >98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg
TheaflavinCat. No.: HY-N0243
Theaflavin is a suitable natural inhibitor againstinfluenza A ( ) neuraminidase.H1N1
Purity: 99.69%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 2 mg, 5 mg, 10 mg, 25 mg
Tilorone dihydrochlorideCat. No.: HY-B1080
Tilorone dihydrochloride is the first recognizedsynthetic, small molecular weight compound that isan orally active interferon inducer, used as anantiviral drug.
Purity: 99.94%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg
Tofacitinib citrate (Tasocitinib citrate; CP-690550 citrate) Cat. No.: HY-40354A
Tofacitinib citrate is an orally available inhibitor with s of 1, 20, and 112JAK1/2/3 IC50
nM, respectively. Tofacitinib citrate hasantibacterial, antifungal and antiviralactivities.
Purity: 99.92%Clinical Data: LaunchedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg, 200 mg, 500 mg
TriazavirinCat. No.: HY-19743
Triazavirin is a nucleoside analogue of nucleicacid and an antiviral agent. Triazavirin works byinhibiting the synthesis of viral RNA and DNA andreplication of genomic fragments. Triazavirin isalso an effective protective agent on thetransmission stage of influenza.
Purity: 99.01%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 50 mg
Trifluoperazine D8Cat. No.: HY-B0532S
Trifluoperazine D8 is a deuterium labeledTrifluoperazine. Trifluoperazine is anantipsychotic phenothiazine agent and a selective
antagonist. Trifluoperazineα1-adrenergic receptoris also a potent dopamine D2 receptorinhibitor .
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
Trifluoperazine dihydrochloride (TFP; SKF5019) Cat. No.: HY-B0532A
Trifluoperazine dihydrochloride (TFP) is anantipsychotic phenothiazine agent and a selective
antagonist. Trifluoperazineα1-adrenergic receptordihydrochloride is also a potent dopamine D2
inhibitor.receptor
Purity: >99.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 500 mg
Trimethobenzamide hydrochloride (Ro 2-9578) Cat. No.: HY-12751A
Trimethobenzamide hydrochloride is a blocker ofthe receptor. Trimethobenzamide is anD2
antiemetic used to prevent nausea and vomiting.
Purity: 99.80%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 200 mg, 500 mg
Tubercidin (7-Deazaadenosine) Cat. No.: HY-100126
Tubercidin (7-Deazaadenosine) is an antibioticobtained from .Streptomyces tubercidicusTubercidin inhibits the growth of Streptococcus
(8043) with an of 0.02 μM.faecalis IC50
Purity: 98.68%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg, 100 mg
Tulobuterol hydrochloride (C-78) Cat. No.: HY-W011733
Tulobuterol hydrochloride (C-78) is a long-actingβ -adrenoceptor2 agonist, which reduces thefrequency of exacerbations of chronic obstructive
.pulmonary disease and bronchial asthma.
Purity: 99.82%Clinical Data: LaunchedSize: 10 mM × 1 mL, 50 mg, 100 mg, 500 mg
18 Tel: 609-228-6898 Fax: 609-228-5909 Email: [email protected]
TunicamycinCat. No.: HY-A0098
Tunicamycin is a mixture of homologous nucleosideantibiotic that inhibits andN-linked glycosylationblocks .GlcNAc phosphotransferase (GPT)
Purity: 99.69%Clinical Data: No Development ReportedSize: 2 mg, 5 mg, 10 mg
TyrothricinCat. No.: HY-120435
Tyrothricin is a polypeptide antibiotic mixtureisolated from and consists ofBacillus brevistyrocidines and gramicidins. Tyrothricin showsactivity against , and some .bacteria fungi viruses
Purity: >98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg
Tyrphostin A9 (Tyrphostin 9; Malonoben) Cat. No.: HY-15511
Tyrphostin A9, a inhibitor, is a potentPDGFRinducer of mitochondrial fission. Tyrphostin A9emerged as the most potent and selective of 51tyrosine kinase inhibitors tested against theTNF-induced respiratory burst. Tyrphostin A9 has
activities.anti-influenza virus
Purity: 99.87%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 50 mg, 100 mg, 500 mg
U0126Cat. No.: HY-12031A
U0126 is a potent, non-ATP competitive andselective and inhibitor, withMEK1 MEK2
s of 72 nM and 58 nM, respectively. U0126 isIC50
an and inhibitor.autophagy mitophagy
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
U0126-EtOHCat. No.: HY-12031
U0126 (U0126-EtOH) is a potent, non-ATPcompetitive and selective and MEK1 MEK2inhibitor, with s of 72 nM and 58 nM,IC50
respectively. U0126 is an andautophagy inhibitor.mitophagy
Purity: 98.06%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg, 200 mg, 500 mg
Umifenovir hydrochlorideCat. No.: HY-14904A
Umifenovir hydrochloride is an broad-spectrumantiviral chemical agent which can inhibit cellentry of enveloped viruses by blocking viralfusion with host cell membrane.
Purity: 99.68%Clinical Data: LaunchedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg
UNC0638Cat. No.: HY-15273
UNC0638 selectively inhibits and G9a GLP histone activity with s of lessmethyltransferase IC50
than 15 nM and 19 nM, respectively. UNC0638 hasanti- andFMDV (foot-and-mouth disease virus)anti- activities.VSV (vesicular stomatitis virus)
Purity: 99.87%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg, 100 mg
Vadimezan (DMXAA; ASA-404) Cat. No.: HY-10964
Vadimezan (DMXAA; ASA-404), the tumor vasculardisrupting agent (tumor-VDA), is a murine agonistof the ( )stimulator of interferon genes STINGand also a potent inducer of and othertype I IFNscytokines. Vadimezan has anti-influenza virus
activities.H1N1-PR8
Purity: 99.81%Clinical Data: Phase 3Size: 10 mM × 1 mL, 5 mg, 10 mg, 50 mg, 100 mg
Wulignan A1Cat. No.: HY-N2264
Wulignan A1 is isolated from the stems of. Wulignan A1 exhibitsSchisandra henryi
anti-influenza virus and (a TamifluH1N1 H1N1-TRdrug resistant virus strain) activities.
Purity: >98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg
XanthohumolCat. No.: HY-N1067
Xanthohumol is one of the principal flavonoidsisolated from hops, the inhibitor ofdiacylglycerol acetyltransferase ( ), DGAT COX-1and COX-2, and shows anti-cancer andanti-angiogenic activities.
Purity: 99.60%Clinical Data: Phase 1Size: 10 mM × 1 mL, 5 mg, 10 mg, 25 mg
www.MedChemExpress.com 19
XanthoneCat. No.: HY-N0126
Xanthone is isolated from Mangosteen and is knownto control cell division and growth, apoptosis,inflammation, and metastasis in different stagesof carcinogenesis.
Purity: 99.66%Clinical Data: No Development ReportedSize: 100 mg
YM-201636Cat. No.: HY-13228
YM-201636 is a potent and selective PIKfyveinhibitor with an of 33 nM. YM-201636 alsoIC50
inhibits p110α with an IC of 3.3 μM. YM-20163650
inhibits replication.retroviral
Purity: 98.22%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 2 mg, 5 mg, 10 mg, 50 mg, 100 mg
Z-VRPR-FMK (TFA) (VRPR) Cat. No.: HY-P1407
Z-VRPR-FMK (TFA) (VRPR), a tetrapeptide, is aselective and irreversible MALT1(Mucosa-associated lymphoid tissue lymphomatranslocation protein 1) inhibitor. Z-VRPR-FMK(TFA) can protect against influenza A virus (IAV)infection.
Purity: >98%Clinical Data:Size: 500 μg
ZanamivirCat. No.: HY-13210
Zanamivir is an influenza viral neuraminidaseinhibitor with values of 0.95 nM and 2.7 nMIC50
for influenza A and B, respectively.
Purity: 99.92%Clinical Data: LaunchedSize: 10 mM × 1 mL, 10 mg, 50 mg, 100 mg
α-Vitamin E ((+)-α-Tocopherol; D-α-Tocopherol) Cat. No.: HY-N0683
α-Vitamin E ((+)-α-Tocopherol) is a Vitamin Ederivative. Vitamin E is a fat-solubleantioxidant.
Purity: >98.0%Clinical Data: LaunchedSize: 10 mM × 1 mL, 100 mg, 1 g
β-CyclodextrinCat. No.: HY-107201
β-Cyclodextrin is a cyclic polysaccharide composedof seven units of glucose (α-D-glucopyranose)linked by α-(1,4) type bonds. β-Cyclodextrin hasoften been used to enhance the solubility ofdrugs. β-Cyclodextrin has anti-influenza virus
activities.H1N1
Purity: >98.0%Clinical Data: No Development ReportedSize: 10 mM × 1 mL, 500 mg, 1 g
20 Tel: 609-228-6898 Fax: 609-228-5909 Email: [email protected]